(KPTI) Karyopharm - Performance -62.6% in 12m
Compare KPTI with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-92.57%
#188 in Group
Rel. Strength
9.39%
#7210 in Universe
Total Return 12m
-62.55%
#119 in Group
Total Return 5y
-98.05%
#166 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.15
42th Percentile in Group
FCF Yield -91.25%
16th Percentile in Group
12m Total Return: KPTI (-62.6%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: KPTI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KPTI
Total Return (including Dividends) | KPTI | XBI | S&P 500 |
---|---|---|---|
1 Month | 42.08% | 2.02% | 2.87% |
3 Months | -35.68% | -15.44% | -6.42% |
12 Months | -62.55% | -14.02% | 9.87% |
5 Years | -98.05% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | KPTI | XBI | S&P 500 |
1 Month | 77.4% | 57% | 89.4% |
3 Months | -60.1% | -82.3% | -72% |
12 Months | -89.5% | -53.1% | 49.3% |
5 Years | -97.3% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #3 | 39.3% | 38.1% |
3 Month | #114 | -23.9% | -31.3% |
12 Month | #120 | -56.5% | -65.9% |
5 Years | #168 | -97.4% | -99.1% |
FAQs
Does KPTI Karyopharm outperforms the market?
No,
over the last 12 months KPTI made -62.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months KPTI made -35.68%, while XBI made -15.44%.
Over the last 3 months KPTI made -35.68%, while XBI made -15.44%.
Performance Comparison KPTI vs Indeces and Sectors
KPTI vs. Indices KPTI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -17.9% | 39.2% | -51.4% | -72.4% |
US NASDAQ 100 | QQQ | -18.2% | 37.4% | -51.8% | -73.9% |
US Dow Jones Industrial 30 | DIA | -18.2% | 40.5% | -50.4% | -68.9% |
German DAX 40 | DAX | -20.0% | 22.8% | -77.0% | -87.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -18.6% | 35.8% | -50.6% | -68.2% |
Hongkong Hang Seng | HSI | -21.4% | 25.9% | -60.9% | -74.6% |
India NIFTY 50 | INDA | -15.5% | 39.8% | -53.3% | -64.9% |
Brasil Bovespa | EWZ | -20.0% | 30.6% | -60.6% | -56.1% |
KPTI vs. Sectors KPTI is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -18.1% | 38.4% | -57.6% | -82.9% |
Consumer Discretionary | XLY | -18.8% | 38.6% | -49.2% | -76.6% |
Consumer Staples | XLP | -17.5% | 40.1% | -58.3% | -70.1% |
Energy | XLE | -18.9% | 42.0% | -45.4% | -52.8% |
Financial | XLF | -18.5% | 36.5% | -57.3% | -84.1% |
Health Care | XLV | -14.1% | 46.5% | -46.2% | -56.6% |
Industrial | XLI | -19.5% | 34.7% | -52.4% | -72.5% |
Materials | XLB | -17.9% | 37.4% | -47.3% | -56.5% |
Real Estate | XLRE | -17.6% | 36.0% | -53.8% | -76.0% |
Technology | XLK | -18.8% | 35.3% | -49.1% | -69.6% |
Utilities | XLU | -19.0% | 36.5% | -59.2% | -78.5% |
Aerospace & Defense | XAR | -18.4% | 32.7% | -60.7% | -87.7% |
Biotech | XBI | -9.83% | 40.1% | -30.3% | -48.5% |
Homebuilder | XHB | -17.5% | 39.0% | -37.8% | -52.8% |
Retail | XRT | -18.1% | 38.5% | -45.1% | -58.2% |